In her first book, Off the Scales, Reuters journalist Aimee Donnellan examines the social and scientific upheaval prompted by GLP-1 weight-loss drugs such as Ozempic, Wegovy and Mounjaro. Donnellan frames the drugs’ emergence against entrenched judgments about body size and beauty norms, citing examples such as a 2022 Times column